KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Goodwill & Intangibles (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Goodwill & Intangibles for 16 consecutive years, with $6.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $6.3 million, compared with a TTM value of $6.3 million through Sep 2025, changed N/A, and an annual FY2024 reading of $4.3 million, down 45.78% over the prior year.
  • Goodwill & Intangibles was $6.3 million for Q3 2025 at TherapeuticsMD, down from $6.3 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $48.4 million in Q2 2022 and bottomed at $4.3 million in Q4 2024.
  • Average Goodwill & Intangibles over 5 years is $21.9 million, with a median of $8.0 million recorded in 2023.
  • The sharpest move saw Goodwill & Intangibles soared 681.1% in 2021, then crashed 82.78% in 2022.
  • Year by year, Goodwill & Intangibles stood at $40.3 million in 2021, then plummeted by 82.78% to $6.9 million in 2022, then grew by 14.78% to $8.0 million in 2023, then plummeted by 45.78% to $4.3 million in 2024, then surged by 44.85% to $6.3 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for TXMD at $6.3 million in Q3 2025, $6.3 million in Q2 2025, and $6.3 million in Q1 2025.